Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method
Key Elements for Standardized Reporting in Prostate Cancer Management: An Expert Delphi Consensus Study
2 other identifiers
observational
10
1 country
1
Brief Summary
This study formulates consensus agreement on clinical key elements related to prostate cancer care that are critical for standardization and global reported using a robust Delphi technique, completely remote and electronic. The goal of this survey study is to have a panel of specialty-specific experts create a consensus agreement on a minimum set of key data elements for use in standardized reports. These recommendations would be used to develop standardized methods to report key data in electronic health records to better manage cancer patients at time of diagnosis, treatment, follow up, and into survivorship.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2021
CompletedStudy Start
First participant enrolled
April 15, 2021
CompletedFirst Posted
Study publicly available on registry
September 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2030
May 26, 2026
May 1, 2026
9.3 years
March 21, 2021
May 22, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
To establish a standardized methods to report key data in electronic health records to better manage cancer patients at time of diagnosis, treatment, follow up, and into survivor-ship.
through study completion, an average of a year.
Study Arms (1)
Observational (questionnaire)
Participants complete 3-4 rounds of questionnaires over 20-30 minutes each over 2 weeks.
Interventions
Eligibility Criteria
Participants with board certification in Radiation Oncology, Radiation Physics, Urology, and/or Medical Oncology
You may qualify if:
- Age 21 and above
- Board certification in Radiation Oncology, Radiation Physics, Urology, and/or Medical Oncology
- Maintenance of an active practice that includes prostate cancer patients
- English speaking
You may not qualify if:
- Medical providers that are not board certified in the professions and/or those who do not treat prostate cancer
- Prisoners, children, and adults unable to consent to participation will also be excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amy C Moreno
M.D. Anderson Cancer Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 21, 2021
First Posted
September 23, 2021
Study Start
April 15, 2021
Primary Completion (Estimated)
August 1, 2030
Study Completion (Estimated)
August 1, 2030
Last Updated
May 26, 2026
Record last verified: 2026-05